Jefferson Health CEO Dr. Stephen Klasko retiring after building system into a powerhouse

Jefferson Health CEO and Thomas Jefferson University President Dr. Stephen K. Klasko is retiring at the end of 2021, after building the health system into the Philadelphia region's largest through a series of significant acquisitions.

In doing so, Klasko has become one of Philadelphia's most influential names not only in health care, but also the business community.

Emeritus Board Trustee H. Richard Haverstick Jr. will become interim president and CEO, effective Jan. 1. Jefferson's board will…

Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 14, 2021 Category: Pharmaceuticals Authors: Ryan Sharrow Source Type: news